- Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
-
Kim KR, Jun CH, Cho KM, Wi JW, Park SY, Cho SB, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS
- KMID: 2381557
- Korean J Intern Med.
- 2015 Sep;30(5):593-601.
- doi: 10.3904/kjim.2015.30.5.593
BACKGROUND/AIMS: To evaluate the efficacy of proton pump inhibitors (PPIs) in reducing rebleeding and bleeding-related death rates after endoscopic gastric variceal obliteration (GVO) using N-butyl-2-cyanoacrylate (NBC). METHODS: This study enrolled 341... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study
-
Kono Y, Okada H, Takenaka R, Miura K, Kanzaki H, Hori K, Kita M, Tsuzuki T, Kawano S, Kawahara Y, Yamamoto K
- KMID: 2382346
- Gut Liver.
- 2016 Jan;10(1):69-75.
- doi: 10.5009/gnl14372
BACKGROUND/AIMS: The interaction between nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori remains controversial. We retrospectively investigated whether H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users. METHODS: From... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection
-
Kim SB, Lee SH, Kim KO, Jang BI, Kim TN
- KMID: 2373354
- Korean J Gastroenterol.
- 2015 Nov;66(5):261-267.
- doi: 10.4166/kjg.2015.66.5.261
BACKGROUND/AIMS: Ten-day sequential therapy has been evaluated as the first line therapy for Helicobacter pylori eradication but studies on sequential therapy as a second line therapy is lacking. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
-
Kim SE, Park MI, Park SJ, Moon W, Choi YJ, Cheon JH, Kwon HJ, Ku KH, Yoo CH, Kim JH, Lee GW, Song SE
- KMID: 2381584
- Korean J Intern Med.
- 2015 Nov;30(6):801-807.
- doi: 10.3904/kjim.2015.30.6.801
BACKGROUND/AIMS: Trends in successful eradication of Helicobacter pylori using first-line triple therapy, consisting of a proton pump inhibitor, amoxicillin, and clarithromycin, have been understudied. We evaluated H. pylori eradication rates... -
- CITED
-
- Close
- SHARE
-
- Close
